Jeff E. Knight, Chief Officer of Alx Oncology Holdings ALXO, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $3.8M. The latest trade was on 04/16.

JK

JK

Jeff E. Knight

Chief Dev & Operating Officer

Company

Alx Oncology Holdings ALXO

First filing

23/03/03

Trades

35 trades

Buys / sales

0 / 10

12-month net buying

−$3.8M

Last trade

04/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	04/08	04/10	85,163 sh	$40.10	$3,415,036.3	−44.7%
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	03/16	03/18	9,911 sh2 trades	$37.37avg.	$370,411.47	−8.1%
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	25/03/19	25/03/21	7,162 sh2 trades	$34.20avg.	$244,963.8	−7.6%
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	24/11/22	24/11/26	501 sh	$56.52	$28,316.52	−1.0%
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	24/07/15	24/07/17	27,000 sh	$55.00	$1,485,000	−34.3%
CP Crinetics Pharmaceuticals	Open-market sale10b5-1 plan	24/06/26	24/06/28	956 sh	$44.38	$42,427.28	−1.8%
CP Crinetics Pharmaceuticals	Open-market sale	24/03/22	24/03/26	32,359 sh2 trades	$44.31avg.	$1,433,675.01	−38.1%